Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia.

Aldoss, Ibrahim; Yang, Dongyun; Aribi, Ahmed; Ali, Haris; Sandhu, Karamjeet; Al Malki, Monzr M; Mei, Matthew; Salhotra, Amandeep; Khaled, Samer; Nakamura, Ryotaro; Snyder, David; O'Donnell, Margaret; Stein, Anthony S; Forman, Stephen J; Marcucci, Guido; Pullarkat, Vinod.
Haematologica; 103(9): e404-e407, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-29545346